New Mesothelioma Treatment Options Are Emerging for Patients

Although no definitive cure is in sight, the treatment of malignant pleural mesothelioma has entered a promising, much-anticipated phase that goes beyond the multimodal approach that has been the standard of care at specialty centers for the past several years. There is new hope on the horizon. Thoracic surgeon and renowned mesothelioma specialist Dr. Robert Cameron, along with scientist Raymond Wong, Ph.D., and thoracic and cardia surgeon Dr. Svetlana Kotova, recently detailed the changing face of therapy in a paper they co-authored and published in the Cancer Management Research Journal . "With all the ongoing research, real progress is only a matter of time," they wrote. "The list of potential new therapies is long, and the number of clinical trials is impressive." Cameron, director of thoracic surgery at the Ronald Reagan UCLA Medical Center and medical advisor for the Pacific Meso Center in Los Angeles, has been a pioneer in the standard, three-pronged combination that includes lung-sparing surgery, chemotherapy and radiation. Advances Making Mesothelioma Manageable Cameron also believes future therapeutic advances are within reach, turning mesothelioma into a more manageable disease like diabetes. Those advances include systemic therapies that affect the entire body in hopes of killing the cancer and localized treatments that specifically target the tumors. Many advances are part of on-going clinical trials showing promising results. A majority of the new...
Source: Asbestos and Mesothelioma News - Category: Environmental Health Authors: Tags: Treatment & Doctors Source Type: news